Developer docs
API playgroundTry for free, no card

Search company profiles

YJ. Biotechnology Co.,Ltd

Full company profile

uuid003fllv

Namestring
YJ. Biotechnology Co.,Ltd
Legal namestring
YJ. Biotechnology Co.,Ltd
Websiteurl
yj-bio.com
Company typeenum
Private
Founded yearint
2020
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew City, United States
HQ citystring
New City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell manufacturing equipment, pharmaceutical isolator systems, GMP cell production, CDMO cell therapy services, exosome manufacturing technology
Industry2 codes
PRIMARYHLAGABAD
Cell Therapy CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code1 code
  • Pharmaceutical and Medicine Manufacturing3254
SIC code3 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
  • Laboratory Analytical Instruments3826
Product category
Cell Manufacturing Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Equipment Sales (YJ-Isolator and related equipment)
TypeHardware Sales
Description

Sale and installation of the proprietary YJ-Isolator system and related pharmaceutical-grade manufacturing equipment (filling lines, lyophilizers, capping systems) to medical institutions and biotechnology companies.

2CDMO Services (Contract Development and Manufacturing Organization)
TypeProfessional Services
Description

Exosome contract manufacturing, sterile filling, and freeze-drying services; stem cell and immune cell contract manufacturing; OEM services for exosome-based beauty products; technology development services.

yj-bio.com
3Turn-Key Factory Planning and Setup Services
TypeProfessional Services
Description

Complete design, construction, and operational maintenance services for micro-intelligent cell preparation factories, including URS definition, layout design, IQ/OQ/PQ validation, regulatory certification, and technical services.

yj-bio.com
4Cell Manufacturing Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary cell manufacturing processes, SOPs, and technology to partners for clinical and commercial cell therapy production.

Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom quotation for equipment and CDMO services based on client requirements, production scale, and service scope.
ModelOtherBilling cadenceMulti-year contract
Notes

Each project is quoted individually based on specific requirements including equipment configuration, production capacity, validation scope, and service duration.

yj-bio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

YJ. Biotechnology develops and manufactures the YJ-Isolator, Taiwan's first domestically produced pharmaceutical-grade aseptic isolation device purpose-built for cell mass production, and provides an integrated cell manufacturing platform combining high-efficiency cell expansion, AIoT process monitoring, and PIC/S GMP-compliant isolator technology. The company sells equipment, turnkey factory design/build services, CDMO cell and exosome contract manufacturing, and licenses its cell manufacturing technology to medical institutions and biotech companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 80% reduction in electricity costs compared to traditional cleanroom manufacturing
+5 more records
Product overview1 text field

YJ. Biotechnology Co.,Ltd offers an integrated cell manufacturing platform combining the YJ-Isolator as the core pharmaceutical-grade isolation system with supporting modules (AIoT monitoring, aseptic filling, lyophilization, and vial capping). The platform enables decentralized point-of-care cell manufacturing for immune cells, stem cells, and exosomes under PIC/S GMP conditions. The company provides turnkey factory design/build/operation services, CDMO manufacturing services, and quality testing under ISO/IEC 17025 certification.

Product and service10 records
1YJ-Isolator (Cell Pharmaceutical Aseptic Isolation Device)
CategoryCell Manufacturing Equipment
Description

Taiwan's first domestically manufactured pharmaceutical-grade isolator specifically designed for large-scale cell manufacturing. Features modular, miniature, and intelligent design with RTP fast-connect incubator, H2O2 sterilizer, microscope, and centrifuge integrated into a Class A ISO 5 environment within ISO 8 background, complying with PIC/S GMP standards. Sold to medical institutions and biotechnology companies.

2AIoT Cell Process System (AIoT Cell Manufacturing Process)
CategoryCell Process Monitoring Software
Description

AIoT-driven cell manufacturing monitoring system combining artificial intelligence and IoT technology for real-time environmental monitoring and data recording. Includes AI auxiliary decision support, digital production records, and remote IoT factory monitoring compliant with FDA 21 CFR Part 11. Sold as a standalone platform to biotech and pharma manufacturers.

3YJ Aseptic Bio-Filling Line (YJ-52403)
CategoryAseptic Filling Equipment
Description

Aseptic filling equipment integrated with H2O2 sterilization and RTP (Rapid Transfer Port) systems for automated filling within a Class A environment. Sold as a standalone equipment unit to biotech manufacturers and CDMO clients.

4YJ Shelf Lyophilizer (YJ-52404)
CategoryLyophilization Equipment
Description

Freeze-drying equipment with dual-chamber design and precise temperature control for efficient lyophilization, designed for integration with the YJ-Isolator platform for closed-system aseptic freeze-drying of exosomes and biologics.

5YJ Vial Capping Line (YJ-52405)
CategoryAseptic Capping Equipment
Description

Automated vial capping system that completes vial sealing within the closed isolator environment without exposure to open areas, enabling the complete aseptic production line for injectable and lyophilized products.

6Mini Intelligent Cell Therapy Product Factory (Turnkey Factory Solution)
CategoryTurnkey Manufacturing Facility Services
Description

Turnkey solution for designing, constructing, and operating decentralized point-of-care cell manufacturing facilities. Combines modular design with exclusive high-efficiency processes for cell mass production in limited spaces with economic benefits. Includes URS definition, layout design, IQ/OQ/PQ validation, regulatory certification, and technical services for hospitals and biotech companies.

7Exosome Products
CategoryExosome Products
Description

Human umbilical cord-derived exosome products available in 500 billion and 3000 billion vesicle specifications. Produced using aseptic lyophilization technology allowing room temperature storage for one year with 90% bioactivity retention after reconstitution. Supplied to biotech companies and medical aesthetics brands.

8Immune Cell Therapy Products
CategoryCell Therapy Products
Description

Cell therapy products including CIK (Cytokine-Induced Killer Cells), NK (Natural Killer Cells), DC-CIK, and gamma-delta T cells for cancer treatment applications, manufactured under GMP-compliant conditions and supplied to medical institutions for clinical use.

9Stem Cell Products
CategoryStem Cell Products
Description

Stem cell products including umbilical cord mesenchymal stem cells (UC-MSCs) and adipose-derived stem cells (ADSCs) for regenerative medicine applications including neurological, cardiovascular, and orthopedic treatments. Supplied to hospitals and research institutions.

10CDMO Contract Development and Manufacturing Services
CategoryContract Manufacturing Services
Description

Contract development and manufacturing services including exosome OEM cosmetics, exosome manufacturing with aseptic filling and lyophilization, technical development, and cell manufacturing services for biotech and pharmaceutical clients.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in cell and gene therapy CDMO services with multiple GMP manufacturing sites. Comparable as a large incumbent offering commercial-scale cell therapy manufacturing services and equipment, though operating a centralized mega-factory model rather than YJ's decentralized point-of-care thesis.

TypeBroad incumbent
Description

Major bioprocessing equipment and services provider under Danaher, supplying cell therapy manufacturing infrastructure globally. Comparable in providing cell therapy manufacturing equipment and services, though as part of a much broader bioprocessing portfolio.

TypeEmerging player
Description

Cell and gene therapy manufacturing platform company focused on automated, closed-system cell processing. Comparable as an emerging player pursuing decentralized and scalable cell therapy manufacturing, though focused on process automation rather than pharmaceutical-grade isolators.

TypeEmerging player
Description

Cell and gene therapy raw materials and manufacturing services provider now part of Sartorius. Comparable as a supplier to cell therapy manufacturers with GMP-grade products, though focused on media and reagents rather than manufacturing equipment platforms.

TypeBroad incumbent
Description

Major global CDMO with cell therapy development and manufacturing capabilities across biologics and gene therapy. Comparable in providing contract cell manufacturing services, but at much larger scale and broader modality coverage than YJ's specialized cell therapy focus.

TypeDirect peer
Description

US-based cell therapy manufacturing automation company pursuing a similar decentralized point-of-care manufacturing thesis. Directly comparable as both companies target automated, closed-system cell manufacturing closer to patients, though Cellares focuses on automation robotics versus YJ's isolator-based approach.

TypeBroad incumbent
Description

Global CDMO with cell therapy, gene therapy, and biologics manufacturing capabilities. Comparable in providing cell therapy contract manufacturing services, though offering a broader portfolio of services at commercial scale versus YJ's specialized point-of-care focus.

TypeBroad incumbent
Description

Asia's largest biologics CDMO with growing cell therapy capabilities and a similar Asia-Pacific geographic footprint. Comparable as a CDMO serving cell therapy developers in the region, though operating at much larger scale and broader modality coverage.

TypeDirect peer
Description

Cell processing technology and instrument provider serving cell therapy developers and research institutions globally. Comparable in providing equipment and consumables for cell manufacturing, including closed-system processing devices, though focused on magnetic cell separation rather than pharmaceutical isolators.

TypeDirect peer
Description

Cell processing and cryopreservation equipment provider for cell therapy applications. Comparable as a provider of automated cell manufacturing and processing equipment used by hospitals and cell therapy developers, though focused on cryopreservation rather than aseptic isolator-based production.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

YJ. Biotechnology Co.,Ltd

Cell Manufacturing Equipmentyj-bio.com

YJ. Biotechnology Co.,Ltd firmographics

Firmographics
Name
YJ. Biotechnology Co.,Ltd
Legal name
YJ. Biotechnology Co.,Ltd
Website
https://yj-bio.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

YJ. Biotechnology Co.,Ltd industry classification

Industry
Product category
Cell Manufacturing Equipment
NAICS
Pharmaceutical and Medicine Manufacturing (3254)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGABAD
Cell Therapy CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Cell manufacturing equipment
  • Pharmaceutical isolator systems
  • GMP cell production
  • CDMO cell therapy services
  • Exosome manufacturing technology

Where YJ. Biotechnology Co.,Ltd is headquartered

Location

Headquarters

HQ city
New City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

YJ. Biotechnology Co.,Ltd business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Equipment Sales (YJ-Isolator and related equipment): Sale and installation of the proprietary YJ-Isolator system and related pharmaceutical-grade manufacturing equipment (filling lines, lyophilizers, capping systems) to medical institutions and biotechnology companies.
  2. CDMO Services (Contract Development and Manufacturing Organization): Exosome contract manufacturing, sterile filling, and freeze-drying services; stem cell and immune cell contract manufacturing; OEM services for exosome-based beauty products; technology development services.
  3. Turn-Key Factory Planning and Setup Services: Complete design, construction, and operational maintenance services for micro-intelligent cell preparation factories, including URS definition, layout design, IQ/OQ/PQ validation, regulatory certification, and technical services.
  4. Cell Manufacturing Technology Licensing: Licensing of proprietary cell manufacturing processes, SOPs, and technology to partners for clinical and commercial cell therapy production.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom quotation for equipment and CDMO services based on client requirements, production scale, and service scope.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

YJ. Biotechnology Co.,Ltd product offering

Product offering

Core offering

YJ. Biotechnology develops and manufactures the YJ-Isolator, Taiwan's first domestically produced pharmaceutical-grade aseptic isolation device purpose-built for cell mass production, and provides an integrated cell manufacturing platform combining high-efficiency cell expansion, AIoT process monitoring, and PIC/S GMP-compliant isolator technology. The company sells equipment, turnkey factory design/build services, CDMO cell and exosome contract manufacturing, and licenses its cell manufacturing technology to medical institutions and biotech companies.

Product overview

YJ. Biotechnology Co.,Ltd offers an integrated cell manufacturing platform combining the YJ-Isolator as the core pharmaceutical-grade isolation system with supporting modules (AIoT monitoring, aseptic filling, lyophilization, and vial capping). The platform enables decentralized point-of-care cell manufacturing for immune cells, stem cells, and exosomes under PIC/S GMP conditions. The company provides turnkey factory design/build/operation services, CDMO manufacturing services, and quality testing under ISO/IEC 17025 certification.

Differentiator

Problem solved

Functional benefit

Products and services

  • YJ-Isolator (Cell Pharmaceutical Aseptic Isolation Device) Taiwan's first domestically manufactured pharmaceutical-grade isolator specifically designed for large-scale cell manufacturing. Features modular, miniature, and intelligent design with RTP fast-connect incubator, H2O2 sterilizer, microscope, and centrifuge integrated into a Class A ISO 5 environment within ISO 8 background, complying with PIC/S GMP standards. Sold to medical institutions and biotechnology companies.
  • AIoT Cell Process System (AIoT Cell Manufacturing Process) AIoT-driven cell manufacturing monitoring system combining artificial intelligence and IoT technology for real-time environmental monitoring and data recording. Includes AI auxiliary decision support, digital production records, and remote IoT factory monitoring compliant with FDA 21 CFR Part 11. Sold as a standalone platform to biotech and pharma manufacturers.
  • YJ Aseptic Bio-Filling Line (YJ-52403) Aseptic filling equipment integrated with H2O2 sterilization and RTP (Rapid Transfer Port) systems for automated filling within a Class A environment. Sold as a standalone equipment unit to biotech manufacturers and CDMO clients.
  • YJ Shelf Lyophilizer (YJ-52404) Freeze-drying equipment with dual-chamber design and precise temperature control for efficient lyophilization, designed for integration with the YJ-Isolator platform for closed-system aseptic freeze-drying of exosomes and biologics.
  • YJ Vial Capping Line (YJ-52405) Automated vial capping system that completes vial sealing within the closed isolator environment without exposure to open areas, enabling the complete aseptic production line for injectable and lyophilized products.
  • Mini Intelligent Cell Therapy Product Factory (Turnkey Factory Solution) Turnkey solution for designing, constructing, and operating decentralized point-of-care cell manufacturing facilities. Combines modular design with exclusive high-efficiency processes for cell mass production in limited spaces with economic benefits. Includes URS definition, layout design, IQ/OQ/PQ validation, regulatory certification, and technical services for hospitals and biotech companies.
  • Exosome Products Human umbilical cord-derived exosome products available in 500 billion and 3000 billion vesicle specifications. Produced using aseptic lyophilization technology allowing room temperature storage for one year with 90% bioactivity retention after reconstitution. Supplied to biotech companies and medical aesthetics brands.
  • Immune Cell Therapy Products Cell therapy products including CIK (Cytokine-Induced Killer Cells), NK (Natural Killer Cells), DC-CIK, and gamma-delta T cells for cancer treatment applications, manufactured under GMP-compliant conditions and supplied to medical institutions for clinical use.
  • Stem Cell Products Stem cell products including umbilical cord mesenchymal stem cells (UC-MSCs) and adipose-derived stem cells (ADSCs) for regenerative medicine applications including neurological, cardiovascular, and orthopedic treatments. Supplied to hospitals and research institutions.
  • CDMO Contract Development and Manufacturing Services Contract development and manufacturing services including exosome OEM cosmetics, exosome manufacturing with aseptic filling and lyophilization, technical development, and cell manufacturing services for biotech and pharmaceutical clients.

Quantifiable outcome

  • 80% reduction in electricity costs compared to traditional cleanroom manufacturing
  • +5 more outcomes

Companies that use YJ. Biotechnology Co.,Ltd

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

YJ. Biotechnology Co.,Ltd technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature7 records

YJ. Biotechnology Co.,Ltd partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves10 records

Expansion highlights6 records

YJ. Biotechnology Co.,Ltd competitors and assessment

Company assessment

Broad incumbents

  • Lonza Group: Global leader in cell and gene therapy CDMO services with multiple GMP manufacturing sites. Comparable as a large incumbent offering commercial-scale cell therapy manufacturing services and equipment, though operating a centralized mega-factory model rather than YJ's decentralized point-of-care thesis.
  • Cytiva (Danaher): Major bioprocessing equipment and services provider under Danaher, supplying cell therapy manufacturing infrastructure globally. Comparable in providing cell therapy manufacturing equipment and services, though as part of a much broader bioprocessing portfolio.
  • Catalent: Major global CDMO with cell therapy development and manufacturing capabilities across biologics and gene therapy. Comparable in providing contract cell manufacturing services, but at much larger scale and broader modality coverage than YJ's specialized cell therapy focus.
  • AGC Biologics: Global CDMO with cell therapy, gene therapy, and biologics manufacturing capabilities. Comparable in providing cell therapy contract manufacturing services, though offering a broader portfolio of services at commercial scale versus YJ's specialized point-of-care focus.
  • WuXi Biologics: Asia's largest biologics CDMO with growing cell therapy capabilities and a similar Asia-Pacific geographic footprint. Comparable as a CDMO serving cell therapy developers in the region, though operating at much larger scale and broader modality coverage.

Emerging players

  • Ori Biotech: Cell and gene therapy manufacturing platform company focused on automated, closed-system cell processing. Comparable as an emerging player pursuing decentralized and scalable cell therapy manufacturing, though focused on process automation rather than pharmaceutical-grade isolators.
  • CellGenix (Sartorius): Cell and gene therapy raw materials and manufacturing services provider now part of Sartorius. Comparable as a supplier to cell therapy manufacturers with GMP-grade products, though focused on media and reagents rather than manufacturing equipment platforms.

Direct peers

  • Cellares: US-based cell therapy manufacturing automation company pursuing a similar decentralized point-of-care manufacturing thesis. Directly comparable as both companies target automated, closed-system cell manufacturing closer to patients, though Cellares focuses on automation robotics versus YJ's isolator-based approach.
  • Miltenyi Biotec: Cell processing technology and instrument provider serving cell therapy developers and research institutions globally. Comparable in providing equipment and consumables for cell manufacturing, including closed-system processing devices, though focused on magnetic cell separation rather than pharmaceutical isolators.
  • ThermoGenesis (a Boai NKY company): Cell processing and cryopreservation equipment provider for cell therapy applications. Comparable as a provider of automated cell manufacturing and processing equipment used by hospitals and cell therapy developers, though focused on cryopreservation rather than aseptic isolator-based production.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

YJ. Biotechnology Co.,Ltd social profiles

Digital presence

YJ. Biotechnology Co.,Ltd compliance and trust

Trust signal

Compliance4 records

YJ. Biotechnology Co.,Ltd financial estimates

Financial estimate

Revenue estimate

Valuation estimate

YJ. Biotechnology Co.,Ltd leadership team

Management profile

Number of profiles

Profiles2 records

YJ. Biotechnology Co.,Ltd funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

YJ. Biotechnology Co.,Ltd M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YJ. Biotechnology Co.,Ltd

What does YJ. Biotechnology Co.,Ltd do?

YJ. Biotechnology develops and manufactures the YJ-Isolator, Taiwan's first domestically produced pharmaceutical-grade aseptic isolation device purpose-built for cell mass production, and provides an integrated cell manufacturing platform combining high-efficiency cell expansion, AIoT process monitoring, and PIC/S GMP-compliant isolator technology. The company sells equipment, turnkey factory design/build services, CDMO cell and exosome contract manufacturing, and licenses its cell manufacturing technology to medical institutions and biotech companies.

Is YJ. Biotechnology Co.,Ltd a public or private company?

YJ. Biotechnology Co.,Ltd is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was YJ. Biotechnology Co.,Ltd founded?

YJ. Biotechnology Co.,Ltd was founded in 2020. It employs 1 to 10 people.

Where is YJ. Biotechnology Co.,Ltd based?

YJ. Biotechnology Co.,Ltd is headquartered in New City, United States, in the North America region.

How does YJ. Biotechnology Co.,Ltd make money?

Four revenue lines are on record. Equipment Sales (YJ-Isolator and related equipment) is the primary driver. The others are CDMO Services (Contract Development and Manufacturing Organization), turn-Key Factory Planning and Setup Services and cell Manufacturing Technology Licensing.

Who are YJ. Biotechnology Co.,Ltd's main competitors?

Broad incumbents on record are Lonza Group, Cytiva (Danaher), Catalent, AGC Biologics and WuXi Biologics. Emerging players are Ori Biotech and CellGenix (Sartorius). Direct peers are Cellares, Miltenyi Biotec and ThermoGenesis (a Boai NKY company).

Does YJ. Biotechnology Co.,Ltd have an API?

No public API is recorded for YJ. Biotechnology Co.,Ltd.

What industry is YJ. Biotechnology Co.,Ltd in?

YJ. Biotechnology Co.,Ltd's product category is Cell Manufacturing Equipment. Its primary akta.pro industry code is HLAGABAD, Cell Therapy CDMO, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 3254 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales